These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease. Giaffer MH, Tindale WB, Holdsworth D. Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940 [Abstract] [Full Text] [Related]
3. [Diagnostic accuracy and clinical significance of combined small bowel enema and scintigraphy with pure fractions of neutrophil granulocytes labeled with HMPAO-Tc99m in chronic intestinal inflammation]. Celentano L, Cirillo LC, D'Arienzo A, De Santis DA. Radiol Med; 1996 Oct; 92(4):398-404. PubMed ID: 9045240 [Abstract] [Full Text] [Related]
4. Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease. Lantto E, Järvi K, Krekelä I, Lantto T, Taavitsainen M, Vedenkangas H, Vorne M. Eur J Nucl Med; 1992 Oct; 19(1):14-8. PubMed ID: 1547802 [Abstract] [Full Text] [Related]
5. Is it possible to assess disease activity of inflammatory bowel disease with scintigraphy? Arndt JW, Grootscholten MI. Neth J Med; 1996 Feb; 48(2):49-52. PubMed ID: 8819798 [Abstract] [Full Text] [Related]
6. Instant technetium 99m hexamethyl propylenamine oxime-labeled leukocyte scan compared with colonoscopy in early assessment of disease extent and activity in acute colitis. Ståhlberg D, Måre K, Granqvist S, Agren B, Richter S, Löfberg R. Dis Colon Rectum; 1996 Oct; 39(10):1146-52. PubMed ID: 8831532 [Abstract] [Full Text] [Related]
7. Leukocyte migration in acute colonic inflammatory bowel disease: comparison of histological assessment and Tc-99m-HMPAO labeled leukocyte scan. Ståhlberg D, Veress B, Måre K, Granqvist S, Agren B, Richter S, Löfberg R. Am J Gastroenterol; 1997 Feb; 92(2):283-8. PubMed ID: 9040207 [Abstract] [Full Text] [Related]
8. [Tc-99m labeled leukocyte scintigraphy and CT for the evaluation of patients with inflammatory bowel disease]. Miyazaki C, Kubo K, Aoyama H, Endoh H, Odashima Y, Saitoh E. Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Jun; 57(7):395-401. PubMed ID: 9232988 [Abstract] [Full Text] [Related]
9. Technetium-99m hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease in children. Bhargava SA, Orenstein SR, Charron M. J Pediatr; 1994 Aug; 125(2):213-7. PubMed ID: 8040764 [Abstract] [Full Text] [Related]
10. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods. Mansfield JC, Giaffer MH, Tindale WB, Holdsworth CD. Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945 [Abstract] [Full Text] [Related]
11. Detection of inflammatory bowel disease in pediatric patients with technetium-99m-HMPAO-labeled leukocytes. Charron M, Orenstein SR, Bhargava S. J Nucl Med; 1994 Mar; 35(3):451-5. PubMed ID: 8113895 [Abstract] [Full Text] [Related]
12. Technetium-99m hexamethyl propylene amine oxime granulocyte scintigraphy in Crohn's disease: diagnostic and clinical relevance. Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P. Gut; 1993 Oct; 34(10):1364-9. PubMed ID: 8244102 [Abstract] [Full Text] [Related]
13. The diagnostic value of Tc-99m human polyclonal immunoglobulin imaging compared to Tc-99m HMPAO labeled leukocytes in inflammatory bowel disease. Delgado Castro M, Lancha C, Prats E, Mitjavilla M, Abós D, Martín-Curto LM, Crespo A, Banzo J. Clin Nucl Med; 1997 Jan; 22(1):17-20. PubMed ID: 8993867 [Abstract] [Full Text] [Related]
14. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease. Allan RA, Sladen GE, Bassingham S, Lazarus C, Clarke SE, Fogelman I. Eur J Nucl Med; 1993 Mar; 20(3):195-200. PubMed ID: 8462606 [Abstract] [Full Text] [Related]
15. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease. Alonso JC, Lopez-Longo FJ, Lampreave JL, González CM, Vegazo O, Carreño L, Almoguera I. Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954 [Abstract] [Full Text] [Related]
16. Scintigraphy with 99mTc-HMPAO labeled leukocytes is still an accurate and convenient tool to rule out suspected inflammatory bowel disease in children. Chroustová D, El-Lababidi N, Trnka J, Černa L, Lambert L. Nucl Med Rev Cent East Eur; 2019 Mar; 22(2):69-73. PubMed ID: 31482559 [Abstract] [Full Text] [Related]
17. Clinical applications of technetium Tc 99m hexamethyl propylene amine oxime leukocyte scan in children with inflammatory bowel disease. Del Rosario MA, Fitzgerald JF, Siddiqui AR, Chong SK, Croffie JM, Gupta SK. J Pediatr Gastroenterol Nutr; 1999 Jan; 28(1):63-70. PubMed ID: 9890471 [Abstract] [Full Text] [Related]
18. Clinical value of technetium-99m-HMPAO-labeled leukocyte scintigraphy and spiral computed tomography in active Crohn's disease. Molnár T, Papós M, Gyulai C, Ambrus E, Kardos L, Nagy F, Palkó A, Pávics L, Lonovics J. Am J Gastroenterol; 2001 May; 96(5):1517-21. PubMed ID: 11374692 [Abstract] [Full Text] [Related]
19. Optimization of technetium-99m-HMPAO leukocyte scintigraphy in evaluation of active inflammatory bowel disease. Sans M, Fuster D, Llach J, Lomeña F, Bordas JM, Herranz R, Piqué JM, Panés J. Dig Dis Sci; 2000 Sep; 45(9):1828-35. PubMed ID: 11052327 [Abstract] [Full Text] [Related]
20. Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label. Schölmerich J, Schmidt E, Schümichen C, Billmann P, Schmidt H, Gerok W. Gastroenterology; 1988 Nov; 95(5):1287-93. PubMed ID: 3169496 [Abstract] [Full Text] [Related] Page: [Next] [New Search]